Comparing serum IgG titers against Chlamydia pneumoniae in patients with early and late-onset pre-eclampsia and healthy individuals

Mokhtari, Mojgan; Yaghmaei, Minoo; Karimi, Mehrbod; Roodbari, Masoud; Koohpaye, Hamid Reza

Comparing serum IgG titers against Chlamydia pneumoniae in patients with early and late-onset pre-eclampsia and healthy individuals

Vol. 7, Issue 4, / January-March 2007
(pages 375-382)

Mojgan Mokhtari: - Department of Obs. & Gyn., Ali-Ebne-Abitaleb Hospital, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Minoo Yaghmaei: - Department of Obs. & Gyn., Ali-Ebne-Abitaleb Hospital, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Mehrbod Karimi: - Department of Pathology, Ali-Ebne-Abitaleb Hospital, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Masoud Roodbari: - Department of Epidemiology & Statistics , Faculty of Health, Zahedan Medical Sciences University, Zahedan, Iran
Hamid Reza Koohpaye: - Department of Infectious Diseases, Bu-Ali Hospital, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Received: 1/1/2007 Accepted: 1/1/2007 - Publisher : Avicenna Research Institute

Other Format

Abstract

Introduction: Pre-eclampsia is one of the complexities of maternal and neonatal health. There are several similarities between pre-eclampsia and atherosclerosis. The relation between chronic Chla-mydia pneumoniae infections with atherosclerosis has been shown previously. This study has been done to determine the connection between pathogenesis and onset time of pre-eclampsia and chro-nic Chlamydia pneumoniae infection. Materials & Methods: This cross-sectional study was done on 88 women with normal pregnancy outcomes, 72 patients with late-onset pre-eclampsia and 16 patients who developed early-onset pre-eclampsia in Zahedan in the years 2004-2005. Anti-Chlamydia IgG and its titer were checked for in the cases and controls by ELISA method. After entering the demographic data and IgG status of the study population, statistical analysis was performed using SPSS software by one-way ANOVA and Chi-Square test, at a significance level of p<0.05. results: the results showed that there were no difference in seropositivity among the three groups (p="0.4)." there were also no differences between early-onset and late-onset pre-eclampsia (p="0.5)," early-onset pre-eclampsia and control group (p="0.32)" and late-onset pre-eclampsia and control group (p="0.25)" in that regard. there was a significant difference in igg titers among the three groups (p<0.0001), between early-onset and late-onset pre-eclampsia (p<0.0001) and between early-onset pre-eclampsia and control group (p<0.0001), but there were no differences between those with late-onset pre-eclampsia and the control group (p="0.98)." conclusion: the results of this study showed that chronic infection with chlamydia pneumoniae could be related to early-onset pre-eclampsia. this study can be a support for evaluating the relationship between pre-eclampsia and subsequent atherosclerosis. therefore, it is suggested that use of macrolides be part of the preventive programs in high-risk individuals for pre-eclampsia.< pan>

Keywords: Pregnancy outcome, Preeclampsia, Chlamydia infections, Chlamydia pneumoniae, Antibodies, ELISA, Atherosclerosis, Macrolides

To cite this article:

Mokhtari M, Yaghmaei M, Karimi M, Roodbari M, Koohpaye HR. Comparing serum IgG titers against Chlamydia pneumoniae in patients with early and late-onset pre-eclampsia and healthy individuals. J Reprod Infertil. 2007;7(4):375-382.

References

Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol. 2000;24(1):24-8. [PubMed]
Campbell DM. Mac Gillivray I. Preeclampsia in twin pregnancies: Incidence and outcome .Hypertens Preg-nancy. 1999;18:197-203. [PubMed]
Von Dadelszen P, Magee LA. Could an infectious trig-ger explain the differential maternal response to the shared placental pathology of preeclampsia a normo-tensive intrauterine growth restriction?. Acta Obstet Gynecol Scand. 2002;81(7):642-8. [PubMed]
Sibai BM. Hypertension. In: Gabbe SG, Niebyl JR, Si-mpson JL. Obstetrics Normal and problem pregnan-cies. 4th Edition, Published by Churchill Livingstone, New York. 2002;pp:945-89.
Roberts JM. Pregnancy-Related Hypertension In: Crea-sy RK, Resnik R. Maternal-Fetal Medicine. 4th Edition, Published by W.B. Saunders Company, Philadelphia. 1999:843.
Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, MeLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-4. [PubMed]
Von Dadelszen P, Magee LA, Marshall JR, Rotstein OD. The maternal syndrome of preeclampsia: a former fruste of the systemic inflammatory response syndrome Sepsis. 2000;4:43-7.
Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):5-15. [PubMed]
Raynor BD, Bonney EA, Jang KT, Coto W, Garcia MS. Preeclampsia and Chlamydia pneumoniae: is there a link? Hypertens Pregnancy. 2004;23(2):129-34. [PubMed]
Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischemic heart disease: a retros-pective cohort study of 129,290 births. Lancet. 2001; 357(9273):2002-6. [PubMed]
Hertig AT. Vascular pathology in the hypertensive albuminuric toxemias of pregnancy. Clinics. 1945;4 (602):614.
Von Dadelszen P, Magee LA, Krajden M, Alasaly K, Popovska V, Devarakonda RM, Money DM, Patrick DM, Brunham RC. Levels of antibodies against cyto-megalovirus and chlamydophila pneumoniae are increased in early onset preeclampsia. BJOG. 2003; 110:725-30. [PubMed]
Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34: 631-8. [PubMed]
Liao JK, Endothelium and acute coronary syndromes. Clin Chem. 1998;44:1799-808. [PubMed]
Silva Neto LB, Ribeiro JP. Infectious agents in coro-nary athero sclerosis. Arq. Bras Cardiol. 1999;73(5): 455-62. [PubMed]
Criqui MH. Epidemiology of cardiovascular disease. In: Goldman L, Ausiello D. Cecil Text Book of Medi-cine. 22nd Edition, Published by Saunders, Philadel-phia. 2004;pp:253.
Morre SA, Stooker W, Lagrand WK, Van den Brule AJC, Niessen HWM. Microorganisms in the etiology of atherosclerosis. J Clin Pathol. 2000;53:647-54. [PubMed]
Heine RP, Ness RB, Roberts JM. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol. 2003;102(1):198-9. [PubMed]
Goulis DG, Chappell L, Gibbs RG, Williams D, Dave JR, Taylor P. Association of raised titers of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG. 2005;112(3):299-305. [PubMed]
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22. [PubMed]
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap lll LC, Wenstrom KD. Williams Obstetrics. 22nd Edition, Published by McGraw-Hill, New York. 2005;pp:762-83.
Vallance P, Collier J, Bhagat K. Infection, infla-mmation and infarction: does acute endothelial dys-function provide a link?. Lancet. 1997;349:1391-2. [PubMed]
Stille W, Dittmann R. Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection. Herz. 1998; 23:185-92. [PubMed]
Maass M. Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences. Herz. 1998;23:187-4. [PubMed]
Goldman L. Cardiovascular Diseases. In: Drazen JM, Gill GN, Griggs RC, Kokko JP, Mandell GL, Powell DW, et al. Cecil Text book of Medicine, 21st Edition, Published by Sannders Company, Philadelphia. 2000: 295.
Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999:34; 631-8. [PubMed]
Liao JK. Endothelium and acute coronary syndromes. Clin Chem. 1998;44:1799-808. [PubMed]
Benitez RM. Atherosclerosis: an infection disease?. Hosp Prac. 1999;34(9):79-90. [PubMed]
Xu Q. Infections, heat shock proteins, and athero-sclerosis. Curr Opin Cardiol. 2003;18(4):245-52. [PubMed]
Boggess KA, Lieff S, Murtha AP, Beck J, Offen-bacher S. Periodontal disease and hypertensive compli-cations of pregnancy [abstract]. Hypertens Pregnancy. 2000;19(supp 1):16.
Faas MM, Schuiling GA, Linton EA, Sargent IL, Redman CW. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol. 2000;182(2):351-357. [PubMed]
Mittendorf R, Lain KY, Williams MA, Walker CK. Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med. 1996;41 (7):491-6. [PubMed]
Agastsuma Y, Fitzpatrick P, Lele A, Kaul A, Ogra PL. Cell-mediated immunity to cytomegalovirus in preg-nant women. Am J Reprod Immunol. 1981;1(4);174-9. [PubMed]
Von Dadelszen P, Magee LA, Lee SK. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity?. Crit Care Med. 2002;30:1883-92. [PubMed]
Von Dadelszen P, Wilkins T, Redman CWG. Mater-nal peripheral blood leukocytes in normal and preec-lamptic pregnancies. Br J Obstet Gynaecol. 1999;106: 576-81. [PubMed]
Chaouat G, Tranchot DJ, Volumenic JL. Immune suppression and Th1/Th2 balance in pregnancy revisi-ted. Am J Reprod Immunol. 1997;37(6):427-34. [PubMed]